Prevention of hepatitis B virus infection from hepatitis B core antibody-positive donor graft using hepatitis B immune globulin and lamivudine in living donor liver transplantation

Liver International

Volumn 25, Issue 6, 2005, Pages 1169-1174

  Suehiro, Taketoshi ^a   Shimada, Mitsuo ^b   Kishikawa, Keiji ^c   Shimura, Tatsuo ^a   Soejima, Yuji ^b   Yoshizumi, Tomoharu ^d   Hashimoto, Kohji ^e   Mochida, Yasushi ^a   Maehara, Yoshihiko ^d   Kuwano, Hiroyuki ^a  

^a GUNMA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c Shiroishi Kyoritu Hospital   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

^e ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

Author keywords

Hepatitis B core antibody; Hepatitis B immune globulin; Hepatitis B recurrence; Lamivudine; Living donor liver transplantation

Indexed keywords

CYCLOSPORIN; HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; LAMIVUDINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS; VIRUS DNA;

ADOLESCENT; ADULT; ALLOGRAFT; ANEMIA; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; FEMALE; FEVER; FOLLOW UP; HEPATITIS B; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; LONG TERM CARE; MALE; REAL TIME POLYMERASE CHAIN REACTION; RECIPIENT; THROMBOCYTOPENIA; VIRUS REACTIVATION; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; COMBINED MODALITY THERAPY; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULINS; LAMIVUDINE; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED;

EID: 28944453534     PISSN: 14783223     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2005.01165.x     Document Type: Article

References (31)

1. Michalak T I, Pasquinelli C, Guilhot S, Chisari F V. Hepatitis B virus persistence after recovery from acute viral hepatitis. J Clin Invest 1994; 93(1): 230-9.
2. Chezouillres O, Mamish D, Kim M, Carey K, Wright T L, Ferrell L, et al. "Occult" hepatitis B virus as a source of infection in liver transplant recipients. Lancet 1994; 343: 142-6.
3. Dickson R C, Everhart J E, Lake J R, Wei Y, Seaberg E C, Wiesner R H, et al. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. Gastroenterology 1997; 113(5): 1668-74.
4. Angus P W, McCaughan G W, Gane E J, Crawford D H, Harley H. Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B. Liver Transplant 2000; 6(4): 429-33.
5. Han S H, Ofman J, Holt C, King K, Kunder G, Chen P, et al. An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy. Liver Transplant 2000; 6(6): 741-8.
6. Markowitz J S, Martin P, Conrad A J, Markmann J F, Seu P, Yersiz H, et al. Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin. Hepatology 1998; 28(2): 585-9.
7. Uemoto S, Sugiyama K, Marusawa H, Inomata Y, Asonuma K, Egawa H, et al. Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants. Transplantation 1998; 65(4): 494-9.
8. Joya-Vazquez P P, Dodson F S, Dvorchik I, Gray E, Chesky A, Demetris A J, et al. Impact of anti-hepatitis Bc-positive grafts on the outcome of liver transplantation for HBV-related cirrhosis. Transplantation 2002; 73(10): 1598-602.
9. Marusawa H, Uemoto S, Hijikata M, Ueda Y, Tanaka K, Shimotohno K, et al. Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen. Hepatology 2000; 31(2): 488-95.
10. Prieto M, Gomez M D, Berenguer M, Cordoba J, Rayon J M, Pastor M, et al. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population. Liver Transplant 2001; 7(1): 51-8.
11. Van Thiel D H, De Maria N, Colantoni A, Friedlander L. Can hepatitis B core antibody positive livers be used safely for transplantation: hepatitis B virus detection in the liver of individuals who are hepatitis B core antibody positive. Transplantation 1999; 68(4): 519-22.
12. Protzer-Knolle U, Naumann U, Bartenschlager R, Berg T, Hopf U, Meyer zum Buschenfelde K H, et al. Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation. Hepatology 1998; 27(1): 254-63.
13. Abe A, Inoue K, Tanaka T, Kato J, Kajiyama N, Kawaguchi R, et al. Quantitation of hepatitis B virus genomic DNA by real-time detection PCR. J Clin Microbiol 1999; 37(9): 2899-903.
14. Pruett T L, McGory R. Hepatitis B immune globulin: the US experience. Clin Transplant 2000; 2(14 Suppl.): 7-13.
15. Sanchez-Fueyo A, Rimola A, Grande L, Costa J, Mas A, Navasa M, et al. Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: a new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation. Hepatology 2000; 31(2): 496-501.
16. Bui Han S H, Martin P. Liver transplantation for hepatitis B. Hepatol Res 2004; 29(4): 193-201.
17. Chan H L, Chui A K, Lau W Y, Chan F K, Hui A Y, Rao A R, et al. Outcome of lamivudine resistant hepatitis B virus mutant post-liver transplantation on lamivudine monoprophylaxis. Clin Transplant 2004; 18(3): 295-300.
18. Roque-Afonso A M, Feray C, Samuel D, Simoneau D, Roche B, Emile J F, et al. Antibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts from anti-HBC positive donors. Gut 2002; 50(1): 95-9.
19. Yu A S, Vierling J M, Colquhoun S D, Arnaout W S, Chan C K, Khanafshar E, et al. Transmission of hepatitis B infection from hepatitis B core antibody - positive liver allografts is prevented by lamivudine therapy. Liver Transplant 2001; 7(6): 513-7.
20. Chen Y S, Wang C C, de Villa V H, Wang S H, Cheng Y F, Huang T L, et al. Prevention of de novo hepatitis B virus infection in living donor liver transplantation using hepatitis B core antibody positive donors. Clin Transplant 2002; 16(6): 405-9.
21. Dodson S F, Bonham C A, Geller D A, Cacciarelli T V, Rakela J, Fung J J. Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors. Transplantation 1999; 68(7): 1058-61.
22. Dodson S F, de Vera M E, Bonham C A, Geller D A, Rakela J, Fung J J. Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation. Liver Transplant 2000; 6(4): 434-9.
23. Loss G E, Mason A L, Blazek J, Dick D, Lipscomb J, Guo L, et al. Transplantation of livers from HBc Ab positive donors into HBc Ab negative recipients: a strategy and preliminary results. Clin Transplant 2001; 6(15 Suppl.): 55-8.
24. Holt D, Thomas R, Van Thiel D, Brems J J. Use of hepatitis B core antibody-positive donors in orthotopic liver transplantation. Arch Surg 2002; 137(5): 572-5.
25. Fabrega E, Garcia-Suarez C, Guerra A, Orive A, Casafont F, Crespo J, et al. Liver transplantation with allografts from hepatitis B core antibody-positive donors: a new approach. Liver Transplant 2003; 9(9): 916-20.
26. Fontana R J, Hann H W, Wright T, Everson G, Baker A, Schiff E R, et al. Lamivudine Compassionate Use Study Group. A multicenter study of lamivudine treatment in 33 patients with hepatitis B after liver transplantation. Liver Transplant 2001; 7(6): 504-10.
27. Malkan G, Cattral M S, Humar A, Al Asghar H, Greig P D, Hemming AW, et al. Lamivudine for hepatitis B in liver transplantation: a single-center experience. Transplantation 2000; 69(7): 1403-7.
28. Seehofer D, Rayes N, Naumann U, Neuhaus R, Muller A R, Tullius S G, et al. Preoperative antiviral treatment and postoperative prophylaxis in HBV-DNA positive patients undergoing liver transplantation. Transplantation 2001; 72(8): 1381-5.
29. De Maria N, Idilman R, Colantoni A, Harig J M, Van Thiel D H. Antibody response to hepatitis B virus vaccination in individuals with hepatitis C virus infection. Hepatology 2000; 32(2): 444-5.
30. Dominguez M, Barcena R, Garcia M, Lopez-Sanroman A, Nuno J. Vaccination against hepatitis B virus in cirrhotic patients on liver transplant waiting list. Liver Transplant 2000; 6(4): 440-2.
31. Chang S H, Suh K S, Yi N J, Choi S H, Lee H J, Seo J K, et al. Active immunization against de novo hepatitis B virus infection in pediatric patients after liver transplantation. Hepatology 2003; 37(6): 1329-34.